Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**ARF GTPase 4 pseudogene 1 (ARF4P1)** is classified as a pseudogene related to the ARF GTPase 4 gene, not as a functional protein-coding gene. ARF4 itself is a GTPase involved in vesicular trafficking and phospholipase D2 regulation, but ARF4P1 lacks functional protein product and is not considered a therapeutic target or relevant in receptor, enzyme, transporter, or other functional classifications[5]. There is no evidence linking ARF4P1 to biological functions, disease roles, or drug interactions, and it is not used as a biomarker. Identifying this name as a pseudogene rather than an active protein target means it should not be used for target-based research or therapeutic development.\n\n**Notes:** \n- There is something wrong with this target: ARF4P1 is a pseudogene, not a therapeutic target or functional protein[5]. \n- For target-based applications, only the functional protein _ARF GTPase 4 (ARF4)_ is relevant, not the pseudogene ARF4P1. \n- No structured or molecular information should be assigned to ARF4P1 beyond its status as a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARF GTPase 4 pseudogene 1 (ARF4P1).